Skip to content

Glue for Cancer Patients: Suyuan Chen Wins Merck Innovation Cup 2021

Dortmund, 24th August 2021

Suyuan Chen, a doctoral student in the Proteomics working group, won the Merck Innovation Cup 2021 with his "Drug Discovery Technologies" team. Together with six other junior scientists from Israel, Canada, London and Munich, he has worked out a plan on how molecular glue can be created and used even better in cancer treatment in the future.

These small molecules stabilise an interplay between proteins that normally hardly interact. In this way, researchers can "glue" disease-causing proteins to others, which the body then destroys. The doctoral students and postdocs from the disciplines of biochemistry, (structural) biology, chemical proteomics and medicinal and organic chemistry are not allowed to talk publicly about the details of their idea.  Merck has taken up the winning idea in order to pursue it further within the Group. "I am not only happy about the win, but especially that our idea could help advance drug development for cancer therapies," says Chen.

Every year, young researchers can apply for a place at the summer camp and competition of the German science and technology company Merck KGaA. After a two-phase selection process in June 2021, based on CV and project ideas, the applicants were divided into six teams: Oncology, Immuno-Oncology, Immunology, Drug Discovery Technologies, Digitalisation and Pandemic Threat. Over the course of a week at the end of June, the teams not only had to develop their ideas but also prepare and present a complete business plan. For Chen and his teammates, the intensive work in the short time was worth it: the team won first place and 20,000 euros, which they can use at their personal leisure.

Change of perspective & more than just a competition

The "Innovation Cup Summer Camp" - which took place online due to the pandemic - offered participants more than just a competition. In lectures and discussion rounds, experts gave them the technical and economic perspective of a company on new research ideas. In addition, the young scientists learned how to successfully present projects to a corporate management. "It's very exciting to learn how the industry thinks and what the business side looks like for them," Chen concludes. Apart from the change of perspective, he especially liked the opportunity to meet so many like-minded people from all over the world: "In such a diverse group, you learn a lot about teamwork and how to deal with criticism." In the future, the 30-year-old would like to keep in touch with his fellow participants through the alumni group and expand his network to include new international partners and friendships. The winners want to use the prize money to finally meet in person as soon as the pandemic allows.

(Cheyenne Peters)

Suyuan Chen presents his Merck Innovation Cup.

Suyuan Chen presents his Merck Innovation Cup.

© ISAS

Share

Further articles

25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.
22nd April 2025

Valuable Connections: Dr Mohammad Ibrahim AlWahsh

Dr Mohammad Ibrahim AlWahsh worked as a research assistant at ISAS during his doctorate. He is now Vice Dean of the Faculty of Pharmacy and Assistant Professor of Toxicological Pathology at Al-Zaytoonah University in Jordan. In the Kompakt series ‘Valuable Connections,’ he reports on his time at ISAS and his ongoing network with the institute.

Mohammad Alwahsh.
9th April 2025

Bacteria & Sweets: Schoolgirls Examine their Breath at the Girls’ Day

On Girls' Day 2025, twelve schoolgirls got to know the work of researchers and technical assistants at the institute. They investigated the cause of and fight against inflammation, went on the hunt for bacteria and used ion mobility spectrometry to analyze the aromatic substances of various sweets in their breath.

Luisa Speicher erklärt drei Mädchen den Vortexmischer.
27th March 2025

Valuable Connections: Dr Jianxu Chen

Dr Jianxu Chen leads the junior research group AMBIOM - Analysis of Microscopic BIOMedical Images at ISAS since 2021. He previously worked at the Allen Institute for Cell Science in Seattle, USA. In the ISAS -Kompakt series ‘Valuable Connections’, the computer scientist reports on his move to health research and to Germany.

Portrait von Dr.  Jianxu Chen.
12th March 2025

Two-step Analysis is a Thing of the Past Thanks to Innovative Mass Spectrometry

Fast and accurate mass spectrometric detection of non-polar substances such as cholesterol together with polar substances? And in just one analysis run? This is made possible by a new combination method that unites two ionization sources in one setup.

Daniel Foest steht im Labor und hält ein Papier mit einer Leberprobe, die er am Massenspektrometer untersucht.